Genome-wide mapping of modifier chromosomal loci for human hypertrophic cardiomyopathy
- 5 April 2007
- journal article
- research article
- Published by Oxford University Press (OUP) in Human Molecular Genetics
- Vol. 16 (20), 2463-2471
- https://doi.org/10.1093/hmg/ddm202
Abstract
Hypertrophic cardiomyopathy (HCM) is a disease of mutant sarcomeric proteins (except for phenocopy). Cardiac hypertrophy is the clinical diagnostic hallmark of HCM and a major determinant of morbidity and mortality in various cardiovascular diseases. However, there is remarkable variability in expression of hypertrophy, even among HCM patients with identical causal mutations. We hypothesized modifier genes are partly responsible for the variation in hypertrophic expressivity. To map the modifier loci, we typed 811 short-tandem repeat markers (∼5 cMdense) in 100 members of an HCM family including 36 with the InsG791 mutation in MYBPC3. We performed oligogenic simultaneous segregation and linkage analyses using Markov Chain Monte Carlo methods and detected linkage on 3q26.2 (180 cM), 10p13 (41 cM), 17q24 (108 cM) with log of the posterior placement probability ratio (LOP) of 3.51, 4.86 and 4.17, respectively, and suggestive linkage (LOP of 2.40) on 16q12.2 (73 cM). The effect sizes varied according to the modifier locus, age and sex. It ranged from ∼8 g shift in left ventricular mass for 10p13 locus heterozygosity for the common allele to ∼90 g shift for 3q26.2 locus homozygosity for the uncommon allele. Refining the 10p13 locus restricted the candidate modifier genes to ITGA8, C10orf97 (CARP) and PTER. ITGA8 and CARP are biologically plausible candidates as they are implicated in cardiac fibrosis and apoptosis, respectively. Since cardiac hypertrophy is a major determinant of total and cardiovascular mortality and morbidity, regardless of the etiology, identification of the specific modifier genes could have significant prognostic and therapeutic implications for various cardiovascular diseases.Keywords
This publication has 31 references indexed in Scilit:
- Ascertainment correction for Markov chain Monte Carlo segregation and linkage analysis of a quantitative traitGenetic Epidemiology, 2007
- CARP is a novel caspase recruitment domain containing pro-apoptotic proteinBiochemical and Biophysical Research Communications, 2002
- Hypertrophic CardiomyopathyJAMA, 2002
- Tissue Doppler Imaging Consistently Detects Myocardial Abnormalities in Patients With Hypertrophic Cardiomyopathy and Provides a Novel Means for an Early Diagnosis Before and Independently of HypertrophyCirculation, 2001
- Regression of left ventricular hypertrophy after nonsurgical septal reduction therapy for hypertrophic obstructive cardiomyopathy.Circulation, 2001
- Variants of Trophic Factors and Expression of Cardiac Hypertrophy in Patients with Hypertrophic CardiomyopathyJournal of Molecular and Cellular Cardiology, 2000
- Magnitude of Left Ventricular Hypertrophy and Risk of Sudden Death in Hypertrophic CardiomyopathyNew England Journal of Medicine, 2000
- Morphology and significance of the left ventricular collagen network in young patients with hypertrophic cardiomyopathy and sudden cardiac deathJournal of the American College of Cardiology, 1999
- Monte carlo markov chain methods for genome screeningGenetic Epidemiology, 1999
- The natural history of isolated left ventricular diastolic dysfunctionAmerican Journal Of Medicine, 1992